560 related articles for article (PubMed ID: 7682024)
1. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
[TBL] [Abstract][Full Text] [Related]
2. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
Tonak J; Hohenberger W; Göhl J
Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
[No Abstract] [Full Text] [Related]
3. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
4. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
5. Effective therapy: repeat limb perfusion for recurrent melanoma.
Krementz ET
J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
[No Abstract] [Full Text] [Related]
6. [Isolated extremity perfusion with TNF-alpha and melphalan in unresectable soft tissue sarcoma. Indications, principles and technique].
Taeger G; Ruchholtz S; Niebel W; Müller S; Nast-Kolb D
Unfallchirurg; 2004 Jul; 107(7):619-23. PubMed ID: 15252711
[No Abstract] [Full Text] [Related]
7. [Isolated hyperthermic extremity perfusion in soft tissue sarcoma].
Eigler FW; Krause U
Chirurg; 1997 Jun; 68(6):649. PubMed ID: 9324449
[No Abstract] [Full Text] [Related]
8. [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
Schlag PM; Kettelhack C
Chirurg; 1993 Jun; 64(6):455-60. PubMed ID: 8359057
[No Abstract] [Full Text] [Related]
9. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
[TBL] [Abstract][Full Text] [Related]
10. [Soft tissue sarcoma: postoperative chemotherapy].
Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
[TBL] [Abstract][Full Text] [Related]
11. Surgical chemotherapy in the management of melanoblastoma of the lower extremities.
Rahóty P; Besznyák I; Erdélyi-Tóth V; Sulvok Z; Péley G
Acta Chir Hung; 1997; 36(1-4):282-3. PubMed ID: 9408375
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
Di Filippo F; Garinei R; Anzà M; Cavaliere F; Giannarelli D; Cagol PP; Rossi CR; Santinami M; Deraco M; Botti C; Perri P; Di Filippo S; Piarulli L; Bruno P
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
[TBL] [Abstract][Full Text] [Related]
13. [Isolated hyperthermic perfusion of the extremities with cytostatic agents. A method of treatment in malignant melanoma and soft tissue sarcoma].
Kettelhack C; Schlag P
Dtsch Krankenpflegez; 1989 Sep; 42(9):597-601. PubMed ID: 2518209
[No Abstract] [Full Text] [Related]
14. Regional chemotherapy by isolation-perfusion.
McBride CM; McMurtrey MJ; Copeland EM; Hickey RC
Int Adv Surg Oncol; 1978; 1():1-9. PubMed ID: 553035
[TBL] [Abstract][Full Text] [Related]
15. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
[TBL] [Abstract][Full Text] [Related]
16. [Regional hyperthermic cytostatic perfusion as an alternative in the treatment of malignant soft tissue tumors of the extremities].
Ghussen F; Nagel K
Chirurg; 1984 Aug; 55(8):505-7. PubMed ID: 6488995
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative adjuvant therapy for primary malignant bone tumors].
Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
[TBL] [Abstract][Full Text] [Related]
18. [Randomized melanoma study of perfusion of the extremities. Results of treatment 2 1/2 years after premature discontinuation].
Ghussen F; Krüger I; Groth W; Stützer H
Chirurg; 1986 Oct; 57(10):619-23. PubMed ID: 3539548
[TBL] [Abstract][Full Text] [Related]
19. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
Hayes AJ; Neuhaus SJ; Clark MA; Thomas JM
Ann Surg Oncol; 2007 Jan; 14(1):230-8. PubMed ID: 17066234
[TBL] [Abstract][Full Text] [Related]
20. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]